Obicetrapib 10 mg for alzheimer disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 31 Aug 2026: Trial registered, NCT07794670

The trials

NCT07794670: Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease

State
Under way
Phase
Phase 2
People
400 planned
Started
Sep 2026
Primary completion
Sep 2028
Arms
Obicetrapib
Results
None posted
  1. 31 Aug 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.